F. Dol

1.2k total citations
36 papers, 922 citations indexed

About

F. Dol is a scholar working on Cell Biology, Hematology and Molecular Biology. According to data from OpenAlex, F. Dol has authored 36 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cell Biology, 14 papers in Hematology and 13 papers in Molecular Biology. Recurrent topics in F. Dol's work include Proteoglycans and glycosaminoglycans research (16 papers), Glycosylation and Glycoproteins Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). F. Dol is often cited by papers focused on Proteoglycans and glycosaminoglycans research (16 papers), Glycosylation and Glycoproteins Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). F. Dol collaborates with scholars based in France, India and Canada. F. Dol's co-authors include Jean‐Marc Herbert, Isabelle Lamarche, B Boneu, Piérre Siè, Pierre Savi, A. Bernat, D. Dupouy, Jean-P. Hérault, Jean‐Pierre Maffrand and Denis Delebassée and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

F. Dol

36 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Dol France 17 378 351 176 166 153 36 922
Paul Braun United States 13 291 0.8× 121 0.3× 212 1.2× 52 0.3× 154 1.0× 22 861
Yi Ma China 13 176 0.5× 252 0.7× 326 1.9× 39 0.2× 149 1.0× 24 942
Amanda J. Unsworth United Kingdom 17 347 0.9× 175 0.5× 264 1.5× 43 0.3× 75 0.5× 43 884
Milica Jakábová Switzerland 7 325 0.9× 91 0.3× 260 1.5× 25 0.2× 84 0.5× 7 776
David C. B. Mills United States 11 276 0.7× 211 0.6× 136 0.8× 34 0.2× 62 0.4× 15 676
J.W.N. Akkerman Netherlands 18 321 0.8× 121 0.3× 408 2.3× 22 0.1× 84 0.5× 35 904
Beverley Koller United States 8 147 0.4× 348 1.0× 322 1.8× 55 0.3× 102 0.7× 9 1.3k
JM Gerrard Canada 15 285 0.8× 78 0.2× 213 1.2× 22 0.1× 36 0.2× 27 661
Alice K. Robison United States 13 121 0.3× 210 0.6× 230 1.3× 33 0.2× 100 0.7× 18 788
Valérie Martin France 13 193 0.5× 116 0.3× 219 1.2× 25 0.2× 63 0.4× 17 665

Countries citing papers authored by F. Dol

Since Specialization
Citations

This map shows the geographic impact of F. Dol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Dol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Dol more than expected).

Fields of papers citing papers by F. Dol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Dol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Dol. The network helps show where F. Dol may publish in the future.

Co-authorship network of co-authors of F. Dol

This figure shows the co-authorship network connecting the top 25 collaborators of F. Dol. A scholar is included among the top collaborators of F. Dol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Dol. F. Dol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marco, Giovana Seno Di, Antoine Alam, F. Dol, et al.. (2008). Angiogenesis and Diabetes: Different Responses to Pro-Angiogenic Factors in the Chorioallantoic Membrane Assay. Molecular Medicine. 14(11-12). 705–714. 6 indexed citations
2.
Hérault, Jean-P., et al.. (1999). Effect of Clopidogrel on Thrombin Generation in Platelet-Rich Plasma in the Rat. Thrombosis and Haemostasis. 81(6). 957–960. 45 indexed citations
3.
Herbert, Jean‐Marc, Françoise Bono, J. Hérault, et al.. (1998). Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.. Journal of Clinical Investigation. 101(5). 993–1000. 64 indexed citations
4.
Herbert, Jean‐Marc, Alexandre Guy, Isabelle Lamarche, et al.. (1997). Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide. Journal of Cellular Physiology. 170(2). 106–114. 16 indexed citations
5.
Dol, F., Anne-Marie Marés, & Jean‐Marc Herbert. (1996). Simvastatin inhibits myointimal hyperplasia following carotid artery injury in cholesterol-fed rabbits. Blood Coagulation & Fibrinolysis. 7(8). 772–778. 12 indexed citations
6.
Herbert, Jean‐Marc, Marie-Claude Laplace, Anne-Marie Marés, & F. Dol. (1995). Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury. PubMed. 12(1). 49–57. 7 indexed citations
7.
Gal, C. Serradeil‐Le, Jean‐Marc Herbert, Paul Schaeffer, et al.. (1995). Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 268(1). H404–H410. 48 indexed citations
8.
9.
Herbert, Jean‐Marc, et al.. (1993). Potentiating Effect of Clopidogrel and SR 46349, a Novel 5-HT2 Antagonist, on Streptokinase-Induced Thrombolysis in the Rabbit. Thrombosis and Haemostasis. 69(3). 268–271. 21 indexed citations
10.
Savi, Pierre, Jean‐Marc Herbert, F. Dol, et al.. (1992). Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochemical Pharmacology. 44(3). 527–532. 161 indexed citations
11.
Boneu, B, C. Caranobe, Sylvie Saivin, F. Dol, & Piérre Siè. (1992). Pharmacokinetics of Heparin and of Dermatan Sulfate: Clinical Implications. Advances in experimental medicine and biology. 313. 237–247. 10 indexed citations
12.
Saivin, Sylvie, F. Dol, C. Caranobe, et al.. (1992). Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbit. Thrombosis Research. 66(5). 527–535. 6 indexed citations
13.
Herbert, Jean‐Marc, Isabelle Lamarche, & F. Dol. (1992). Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin. FEBS Letters. 301(2). 155–158. 69 indexed citations
14.
Boneu, B, F. Dol, C. Caranobe, Piérre Siè, & Georges Houin. (1989). Pharmacokinetics of Heparin and Related Polysaccharidesa. Annals of the New York Academy of Sciences. 556(1). 282–291. 18 indexed citations
15.
Siè, Piérre, et al.. (1989). Neutralization of dermatan sulfate and by protamine sulfate and polybrene. Thrombosis Research. 54(1). 63–74. 6 indexed citations
16.
Dol, F., Georges Houin, M Rostin, et al.. (1989). Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans. Blood. 74(5). 1577–1582. 19 indexed citations
17.
Dol, F., C. Caranobe, D. Dupouy, et al.. (1988). Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties. Thrombosis Research. 52(2). 153–164. 24 indexed citations
18.
Dupouy, D., Piérre Siè, F. Dol, & B Boneu. (1988). A Simple Method to Measure Dermatan Sulfate at Sub-Microgram Concentrations in Plasma. Thrombosis and Haemostasis. 60(2). 236–239. 41 indexed citations
19.
Dol, F., C. Caranobe, Piérre Siè, et al.. (1987). Pharmacokinetics of 125I-pentosan polysulfate in the rabbit. Thrombosis Research. 48(3). 373–378. 3 indexed citations
20.
Siè, Piérre, D. Dupouy, F. Dol, & B Boneu. (1987). Inactivation of heparin cofactor II by polymorphonuclear leukocytes. Thrombosis Research. 47(6). 657–664. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Braun Breakdown of academic impact, for papers by Yi Ma Breakdown of academic impact, for papers by Amanda J. Unsworth Breakdown of academic impact, for papers by Milica Jakábová Breakdown of academic impact, for papers by David C. B. Mills Breakdown of academic impact, for papers by J.W.N. Akkerman Breakdown of academic impact, for papers by Beverley Koller Breakdown of academic impact, for papers by JM Gerrard Breakdown of academic impact, for papers by Alice K. Robison Breakdown of academic impact, for papers by Valérie Martin
Rankless by CCL
2026